Gerardo Canet

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

IntegraMed America, Inc. engages in developing, marketing, and managing specialty outpatient healthcare facilities. It offers a suite of management support and infrastructure such as clinical and business information systems, sales and marketing, facilities and operations management, finance and accounting, human resources, legal, risk management, and quality assurance. The company was founded by Vicki Baldwin and is headquartered in Purchase, NY.

Curative Health Services, Inc. seeks to deliver care and clinical results for patients with serious or chronic medical conditions. The Specialty Infusion business, through its national footprint of Critical Care Systems' local pharmacy branches, provides products, related clinical services and disease management support to patients with chronic or severe conditions, such as hemophilia and other bleeding disorders, chronic or severe infections, gastrointestinal illnesses that prohibit oral digestion and other severe conditions requiring nutritional support, as well as immune systems disorders, cancer and the prevention of respiratory syncytial virus. Th